drugset / Trial / NCT03644966

Probiotics and Multi-Drug Resistant Urinary Tract Infection

NCT03644966

RandomizedParallel-groupDouble-blindTreatment

Summary

This pilot study is a single-site randomized, double blinded placebo-controlled in females with recurrent multi-drug resistant (MDR) urinary tract infections(UTI). Our study hypothesizes that a novel probiotic strain improves antibiotic sensitivity patterns in these former MDR UTIs.

Timeline

Start
2018-07-05
Primary completion
2022-12-15
Completion
2022-12-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium infantis Other / unclassified 1 unknown